Lonza Biologics Tuas Overview

  • Founded
  • 2007

  • Status
  • Private

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.48M

Lonza Biologics Tuas General Information


Provider of a medical research and development services intended to offer large-scale cell culture manufacturing facilities. The company's medical research and development services offers a site for the production of monoclonal antibodies and recombinant proteins, enabling its clients to receive treatment related to large-scale cell culture.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 35 Tuas South Avenue 6
  • Singapore, 637377
  • Singapore
+65 6521 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lonza Biologics Tuas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Aug-2008 $6.48M 000.00 Completed Generating Revenue
2. Early Stage VC Completed Generating Revenue
1. Joint Venture 01-Jan-2007 Completed Generating Revenue
To view Lonza Biologics Tuas’s complete valuation and funding history, request access »

Lonza Biologics Tuas Board Members (1)

Name Representing Role Since
Stephan Kutzer Ph.D Self Chairman 000 0000
To view Lonza Biologics Tuas’s complete board members history, request access »